# Methylphenidate Treatment of Attention Deficits in Epilepsy

> **NCT02178995** · PHASE4 · COMPLETED · sponsor: **Kimford Jay Meador** · enrollment: 55 (actual)

## Conditions studied

- Epilepsy
- Cognitive Deficits
- Attention Deficits

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT02178995
- **Lead sponsor:** Kimford Jay Meador
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-08
- **Primary completion:** 2015-09
- **Final completion:** 2015-12
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2017-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02178995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02178995, "Methylphenidate Treatment of Attention Deficits in Epilepsy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02178995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*